CRISPR Therapeutics AG CRSP
NASDAQ CRSP
$55.32 -0.68 (-1.21%)
At close: Sep 30, 2026 · 4:00 PM EDT

CRISPR Therapeutics AG (CRSP) Other financing activities (2026)

Updated

CRISPR Therapeutics AG (CRSP) recorded Other financing activities of $1.12 million in Q2 2026, down 91.7% from the prior quarter.

Analysis

CRISPR Therapeutics AG (CRSP) Other financing activities (2026) Analysis & Trends

On a TTM basis, CRISPR Therapeutics AG's Other financing activities came in at $14.65 million as of Jun 30, 2026.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 CRISPR Therapeutics AG 5.35 Bn 5.35 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.12 Mn
Mar 31, 2026 13.53 Mn
API Access

CRISPR Therapeutics AG Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=CRSP&period=max&api_key=YOUR_API_KEY